Insider Transactions

What Mereo BioPharma Group plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Lewicki John A.	Chief Scientific Officer	Sep 13	Sale for tax withholding · S	−10,937	$4.22	−$46.2K	78,630
Sermon Charles	General Counsel	Sep 13	Sale for tax withholding · S	−20,946	$4.22	−$88.4K	219,061
Hughes-Wilson Alexandra	See Remarks	Sep 13	Sale for tax withholding · S	−84,008	$4.22	−$355K	50,475
Hughes-Wilson Alexandra	See Remarks	Sep 13	Sale for tax withholding · S	−16,304	$4.22	−$68.8K	134,483
Fox Chrisitne Ann	Chief Financial Officer	Sep 13	Sale for tax withholding · S	−19,158	$4.22	−$80.9K	89,285
Pollard-Knight Denise	Chief Executive Officer	Sep 13	Sale for tax withholding · S	−60,046	$4.22	−$253K	808,921
Lewicki John A.	Chief Scientific Officer	Sep 12	Sale for tax withholding · S	−5,212	$4.47	−$23.3K	89,567
Sermon Charles	General Counsel	Sep 12	Sale for tax withholding · S	−9,980	$4.47	−$44.6K	240,007
Hughes-Wilson Alexandra	See Remarks	Sep 12	Sale for tax withholding · S	−40,029	$4.47	−$179K	150,787
Hughes-Wilson Alexandra	See Remarks	Sep 12	Sale for tax withholding · S	−7,769	$4.47	−$34.7K	190,816
Fox Chrisitne Ann	Chief Financial Officer	Sep 12	Sale for tax withholding · S	−9,128	$4.47	−$40.8K	108,443
Pollard-Knight Denise	Chief Executive Officer	Sep 12	Sale for tax withholding · S	−28,611	$4.47	−$128K	868,967
Lewicki John A.	Chief Scientific Officer	Sep 11	Exercise / conversion · M	+46,000	—	—	94,779
Sermon Charles	General Counsel	Sep 11	Exercise / conversion · M	+65,600	—	—	249,987
Hughes-Wilson Alexandra	See Remarks	Sep 11	Exercise / conversion · M	+40,000	—	—	74,548
Hughes-Wilson Alexandra	See Remarks	Sep 11	Exercise / conversion · M	+75,000	$1.01	+$75.8K	242,881
Hughes-Wilson Alexandra	See Remarks	Sep 11	Exercise / conversion · M	+93,333	$1.40	+$131K	167,881
Fox Chrisitne Ann	Chief Financial Officer	Sep 11	Exercise / conversion · M	+60,000	—	—	117,571
Pollard-Knight Denise	Chief Executive Officer	Sep 11	Exercise / conversion · M	+188,060	—	—	897,578
Pakianathan Deepika	Director	Aug 22	Open-market sale · S	−105,244	$4.43	−$466K	0

Page 1 of 3 · showing the 20 most recent Sign up free to view all 43 transactions and filter by insider →